Controlled Substances Export Reform Act Clears House Subcommittee
This article was originally published in The Pink Sheet Daily
Executive Summary
The bill would allow drug manufacturers to ship controlled substances to foreign sites for further export. Pennsylvania Congressman Pitts (R), who sponsored the legislation, says it will help small pharma companies keep jobs in the U.S.
You may also be interested in...
Bill To Ease Restrictions On Controlled Substance Exports Clears House Commerce Committee
Legislation that would remove certain export restrictions for controlled substances is now under review by the House Judiciary Committee. HR 184 would create “new parity” for U.S. pharmaceutical manufacturers, the bill’s sponsor says.
Bill To Ease Restrictions On Controlled Substance Exports Clears House Commerce Committee
Legislation that would remove certain export restrictions for controlled substances is now under review by the House Judiciary Committee. HR 184 would create “new parity” for U.S. pharmaceutical manufacturers, the bill’s sponsor says.
Exporting Controlled Substances Would Be Easier Under House Bill
The legislation reintroduced by Rep. Joe Pitts (R-Penn.) would allow drug makers to ship controlled substances to foreign distribution sites for further export. Cephalon worked with Pitts to develop the bill due to the high costs of exporting Actiq.